If you've read our piece on allostatic overload, you already know the core idea: your body keeps a running tally of every stressor it absorbs, and when the tally runs too high for too long, the cost shows up in your biology, not just your mood. What we haven't covered yet is a question a lot of you have been asking us directly: can the device on your wrist actually see any of this happening?
The honest answer is: partly, and it's worth understanding exactly which part.
What your wearable is really measuring
Most consumer wearables that claim to track "stress" are really measuring heart rate variability, or HRV, the tiny, natural variation in the time between each heartbeat. It sounds like a strange thing to obsess over, but HRV is one of the more direct windows we have into your autonomic nervous system, the part of you constantly negotiating between rest-and-digest and fight-or-flight without asking your permission first.
Research groups have been validating this for a while now. A pilot study using smartwatch-based HRV tracking found that changes in heart rate variability could meaningfully predict how someone's body responded to an induced stressor, distinguishing recovery quality between people with different baseline stress profiles. Separately, a research review from the Texas Heart Institute noted that consumer-grade HRV monitoring compares reasonably well against medical-grade equipment, and that low HRV correlates with elevated cardiovascular risk.
None of that means your watch is diagnosing you. It means it's picking up a real physiological signal, one that has a genuine relationship with how your body is handling load, which is precisely the territory allostatic load research lives in.
The newer frontier: glucose, not just heart rate
The more interesting shift over the last couple of years has been continuous glucose monitors, or CGMs, moving well beyond their original diabetes-management purpose. A growing body of research is now looking at what glucose variability tells us in people who are entirely non-diabetic, and stress turns up as a genuine part of that picture. One multi-arm observational study tracking non-diabetic and pre-diabetic adults over 14 days found meaningful correlations between glucose variability metrics and established markers of inflammation and stress, including cortisol, alongside sleep and activity data collected in parallel.
That's a notable finding, because it suggests glucose regulation isn't purely a diet story. Your stress load appears to leave fingerprints there too, which lines up with what allostatic load research has argued for years: chronic stress doesn't stay contained in one system.
Want the full evidence review?
Six biomarker systems, a reflective self-check, and the lab targets to raise with your clinician.
Where the honest caution belongs
A device measuring HRV or glucose variability is giving you a data trend, not a verdict. Several of the same research teams validating these devices are equally clear that ultra-short HRV readings carry real reliability limits compared to longer clinical measurements, and that accuracy varies meaningfully between devices, wear position, and even how still you're sitting when the reading happens.
In plain terms: a rough night on your recovery score isn't a diagnosis, and a green ring on your app isn't a clean bill of health. These tools are best used the way a good weather forecast is used, as a trend worth paying attention to, not a fact to build your identity around.
So what should you actually do with the data?
If you're already wearing something that tracks HRV, sleep, or glucose, the most useful shift isn't buying a fancier device, it's changing what question you ask the data. Instead of "is this number good or bad today," try "what does the trend over the last two to three weeks look like, and does it move in the direction I'd expect when I'm actually resting versus when I'm not."
This is exactly the kind of practical, evidence-grounded question we'll keep exploring, including a closer look at vagus nerve function and the cholinergic anti-inflammatory reflex, and what HbA1c reveals about long-term stress load, both of which show up in the numbers you're already collecting. If you're curious how reliable that wrist or ring data actually is device by device, we've broken down the 2025-2026 validation studies in detail.
Sources
Findings referenced above draw on a 2022 MDPI Sensors pilot study on smartwatch HRV and stress detection, a Texas Heart Institute research review on wearable HRV monitoring, a 2025 Nature Scientific Data continuous HRV/sleep dataset study, and a 2024 Scientific Reports study on continuous glucose monitoring correlating glycemic variability with cortisol and inflammatory markers in non-diabetic adults.
Start with a baseline
The Burnout Biomarker Checklist
A 13-page evidence review covering six biomarker systems, a reflective self-check, and the specific lab targets to raise with your clinician. Free.
Start with the Self-Check on page 11. It takes about four minutes.
The Capio Initiative is an educational and resilience-training platform. We are not a medical practice. The topics discussed are for physiological understanding and burnout recovery, not diagnostic criteria for medical disease. Speak with a qualified healthcare professional before changing anything about your recovery, training, or use of tracking hardware.
